Lyra Therapeutics, Inc. (LYRA) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 1.77M | +35.5% |
| 2024 | 1.31M | -97.7% |
| 2023 | 57.21M | +79.8% |
| 2022 | 31.83M | +144.7% |
| 2021 | 13.01M | +0.6% |
| 2020 | 12.93M | +5501.8% |
| 2019 | 230.9K | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 1.77M | +35.5% |
| 2024 | 1.31M | -97.7% |
| 2023 | 57.21M | +79.8% |
| 2022 | 31.83M | +144.7% |
| 2021 | 13.01M | +0.6% |
| 2020 | 12.93M | +5501.8% |
| 2019 | 230.9K | — |